Author:
Tremblay-Mercier Jennifer,Madjar Cécile,Das Samir,Pichet Binette Alexa,Dyke Stephanie O.M.,Étienne Pierre,Lafaille-Magnan Marie-Elyse,Remz Jordana,Bellec Pierre,Louis Collins D.,Natasha Rajah M.,Bohbot Veronique,Leoutsakos Jeannie-Marie,Iturria-Medina Yasser,Kat Justin,Hoge Richard D.,Gauthier Serge,Tardif Christine L.,Mallar Chakravarty M.,Poline Jean-Baptiste,Rosa-Neto Pedro,Evans Alan C.,Villeneuve Sylvia,Poirier Judes,Breitner John C.S.
Funder
Pfizer Canada ULC
Government of Canada
McGill University
Quebec Health Research Fund
Subject
Cognitive Neuroscience,Neurology (clinical),Neurology,Radiology, Nuclear Medicine and imaging
Reference40 articles.
1. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria;Dubois;Alzheimer's & Dementia,2016
2. Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis;Iturria-Medina;Nat. Commun.,2016
3. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study;Villemagne;The Lancet Neurology,2013
4. Rationale and Structure for a New Center for Studies on Prevention of Alzheimer's Disease (StoP-AD);Breitner;The journal of prevention of Alzheimer's disease,2016
5. APOE-ε4 count predicts age when prevalence of AD increases, then declines: the Cache County Study;Breitner;Neurology,1999